New Search

Your search found 80 records, sorted by year and then date of acquisition.

1. Prescription Opioid Registry Protocol in an Integrated Health System. doc type
  Ray, G. Thomas ; Bahorik, Amber L. ; VanVeldhuisen, Paul C. ; Weisner, Constance M. ; Rubinstein, Andrea L. ; Campbell, Cynthia I.
 American Journal of Managed Care 2017;23(5):e146-e155..
 
2. High Mortality Among Patients with Opioid Use Disorder in a Large Healthcare System. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Zhu, Yuhui ; Liang, Di ; Huang, David
 Journal of Addiction Medicine 2017 (in press). [doi: 10.1097/ADM.0000000000000312].
 
3. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
4. Chronic Pain Among Patients with Opioid Use Disorder: Results from Electronic Health Records Data. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Huang, David
 Journal of Substance Abuse Treatment 2017;77:2630. [doi: 10.1016/j.jsat.2017.03.006].
 
5. Volatility and Change in Chronic Pain Severity Predict Outcomes of Treatment for Prescription Opioid Addiction. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Addiction 2017 (in press). [doi: 10.1111/add.13782].
 
6. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
7. Causes of Death and Expected Years of Life Lost Among Treated Opioid-Dependent Individuals in the United States and Taiwan. doc type
  Chang, Kun-Chia ; Wang, Jung-Der ; Saxon, Andrew J. ; Matthews, Abigail G. ; Woody, George E. ; Hser, Yih-Ing
 International Journal of Drug Policy 2017;45:1-6. [doi: 10.1016/j.drugpo.2016.12.003].
 
8. Identifying Substance Misuse in Primary Care: TAPS Tool Compared to the WHO ASSIST. doc type
  Schwartz, Robert P. ; McNeely, Jennifer ; Wu, Li-Tzy ; Sharma, Gaurav ; Wahle, Aimee ; Cushing, Carol ; Nordeck, Courtney ; Sharma, Anjalee ; O'Grady, Kevin E. ; Gryczynski, Jan ; Mitchell, Shannon G. ; Ali, Robert L. ; Marsden, John ; Subramaniam, Geetha A.
 Journal of Substance Abuse Treatment 2017;76:6976. [doi: 10.1016/j.jsat.2017.01.013].
 
9. CSAT/CTN Webinar: NIDA CTN Initiatives and Primary Care Opioid Use Disorders Treatment Trial Briefing. doc type
  Johnson, Kimberly ; Tai, Betty ; Bradley, Katharine
 Webinar presented October 19, 2016.
 
10. An Item Bank for Abuse of Prescription Pain Medication from the Patient-Reported Outcomes Measurement Information System (PROMIS). doc type
  Pilkonis, Paul A. ; Yu, Lan ; Dodds, Nathan E. ; Johnston, Kelly L. ; Lawrence, Suzanne M. ; Hilton, Thomas F. ; Daley, Dennis C. ; Patkar, Ashwin A. ; McCarty, Dennis
 Pain Medicine 2016 (in press). [doi: 10.1093/pm/pnw233].
 
11. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
12. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. doc type
  McNeely, Jennifer ; Wu, Li-Tzy ; Subramaniam, Geetha A. ; Sharma, Gaurav ; Cathers, Lauretta A. ; Svikis, Dace S. ; Sleiter, Luke ; Russell, Linnea ; Nordeck, Courtney ; Sharma, Anjalee ; O'Grady, Kevin E. ; Bouk, Leah B. ; Cushing, Carol ; King, Jacqueline ; Wahle, Aimee ; Schwartz, Robert P.
 Annals of Internal Medicine 2016;165(10):690-699. [doi: 10.7326/M16-0317].
 
13. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
14. Hair Analysis and Its Concordance with Self-Report for Drug Users Presenting in Emergency Departments. doc type
  Sharma, Gaurav ; Oden, Neal L. ; VanVeldhuisen, Paul C. ; Bogenschutz, Michael P.
 Drug and Alcohol Dependence 2016;167:149-155. [doi: 10.1016/j.drugalcdep.2016.08.007].
 
15. Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool. doc type
  Wu, Li-Tzy ; McNeely, Jennifer ; Subramaniam, Geetha A. ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Schwartz, Robert P.
 Contemporary Clinical Trials 2016;50:90-97. [doi: 10.1016/j.cct.2016.07.013].
 
16. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
17. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
18. Longitudinal Association Between Pain Severity and Subsequent Opioid Use in Prescription Opioid Dependent Patients with Chronic Pain. doc type
  Griffin, Margaret L. ; McDermott, Katherine A. ; McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Jamison, Robert N. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2016;163(1):216-221. [doi: 10.1016/j.drugalcdep.2016.04.023].
 
19. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
20. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Experimental and Clinical Psychopharmacology 2015;23(6):428-435. [doi: 10.1037/pha0000039].
 
21. Exploring the Relationship Between Eating Disorder Symptoms and Substance Use Severity in Women with Comorbid PTSD and Substance Use Disorders. doc type
  Killeen, Therese ; Brewerton, Timothy D. ; Campbell, Aimee N. C. ; Cohen, Lisa R. ; Hien, Denise A.
 American Journal of Drug and Alcohol Abuse 2015;41(6):547-52. [doi: 10.3109/00952990.2015.1080263].
 
22. Predictors of Agreement Between Hair Analysis and Self Report of Drug Use. doc type
  VanVeldhuisen, Paul C. ; Sharma, Gaurav ; Bogenschutz, Michael P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
23. Using Behavioral Economics to Predict Outcomes of Medication and Counseling for Prescription Opioid Dependence. doc type
  Worley, Matthew J. ; Shoptaw, Steven ; Bickel, Warren K. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
24. Health-Related Quality of Life Among Prescription Opioid-Dependent Patients: Results from a Multi-Site Study. doc type
  Griffin, Margaret L. ; Bennett, Heather E. ; Fitzmaurice, Garrett M. ; Hill, Kevin P. ; Provost, Scott E. ; Weiss, Roger D.
 American Journal on Addictions 2015;24(4):308-314. [doi: 10.1111/ajad.12188].
 
25. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
26. Web-Based Treatment for Substance Use Disorders: Differential Effects by Primary Substance. doc type
  Cochran, Gerald ; Stitzer, Maxine L. ; Campbell, Aimee N. C. ; Hu, Mei-Chen ; Vandrey, Ryan ; Nunes, Edward V.
 Addictive Behaviors 2015;45:191-194. [doi: 10.1016/j.addbeh.2015.02.002].
 
27. Developing PCORI Applications for Patient-Centered SUD Treatment Research: A CTN Technical Assistance Workshop. doc type doc type
  Tai, Betty ; Chandler, Redonna K. ; Selby, Joe ; Hickam, David ; Luce, Bryan ; Ling, Walter ; Brooks, Adam ; Campbell, Cynthia ; Ford, Jay
 Workshop held at the National Institute of Drug Abuse (NIDA), January 8, 2015.
 
28. Community Perspectives on Drug/Alcohol Use, Concerns, Needs and Resources in Four Washington State Tribal Communities. doc type
  Radin, Sandra M. ; Kutz, Stephen H. ; LaMarr, June ; Vendiola, Diane ; Vendiola, Michael ; Wilbur, Brian ; Thomas, Lisa Rey ; Donovan, Dennis M.
 Journal of Ethnicity in Substance Abuse 2015;14(1):29-58. [doi: 10.1080/15332640.2014.947459].
 
29. Opioid Withdrawal, Craving, and Use During and After Outpatient Buprenorphine Stabilization and Taper: A Discrete Survival and Growth Mixture Model. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Walker, N. Robrina ; Weiss, Roger D. ; Trivedi, Madhukar H.
 Addictive Behaviors 2015;41:20-28. [doi: 10.1016/j.addbeh.2014.09.021].
 
30. Denial of Urinalysis-Confirmed Opioid Use in Prescription Opioid Dependence. doc type
  Hilario, E. Yvette ; Griffin, Margaret L. ; McHugh, R. Kathryn ; McDermott, Katherine A. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):85-90. [doi: 10.1016/j.jsat.2014.07.003].
 
31. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
32. Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population. doc type
  McDermott, Katherine A. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Hilario, E. Yvette ; Fiellin, David A. ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Clinical Psychiatry 2015;76(2):189-194. [doi: 10.4088/JCP.14m09096].
 
33. Using Behavioral Economics to Predict Opioid Use During Prescription Opioid Dependence Treatment. doc type
  Worley, Matthew J. ; Shoptaw, Steven J. ; Bickel, Warren K. ; Ling, Walter
 Drug and Alcohol Dependence 2015;148:62-68. [doi: 10.1016/j.drugalcdep.2014.12.018].
 
34. Association Between Hepatitis C Virus and Opioid Use While in Buprenorphine Treatment: Preliminary Findings. doc type
  Murphy, Sean M. ; Dweik, Dana ; McPherson, Sterling ; Roll, John M.
 American Journal of Drug and Alcohol Abuse 2014;41(1):88-92. [doi: 10.3109/00952990.2014.983274].
 
35. Client and Provider Views on Access to Care for Substance-Using American Indians: Perspectives from a Northern Plains Urban Clinic. doc type
  Kropp, Frankie B. ; Lilleskov, Maurine ; Richards, Jennifer ; Somoza, Eugene C. ; CTN-0033-Ot-4 Team
 American Indian and Alaska Native Mental Health Research 2014;21(2):43-65. [doi: 10.5820/aian.2101.2014.43].
 
36. Assessing Craving and Its Relationship to Subsequent Prescription Opioid Use Among Treatment-Seeking Prescription Opioid Dependent Patients. doc type
  McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Carroll, Kathleen M. ; Griffin, Margaret L. ; Hill, Kevin P. ; Wasan, Ajay D. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2014;145:121-126. [doi: 10.1016/j.drugalcdep.2014.10.002].
 
37. Improving Treatment for Opioid Dependence: A Perspective from the Ohio Valley Node of the NIDA Clinical Trials Network. doc type
  Winstanley, Erin L. ; Brigham, Gregory S. ; Babcock, Dean ; Winhusen, Theresa M.
 Progress in Community Health Partnerships: Research, Education, and Action 2014;8(1):99-107. [doi: 10.1353/cpr.2014.0002].
 
38. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
39. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
40. Reasons for Opioid Use Among Patients with Dependence on Prescription Opioids: The Role of Chronic Pain. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; McHugh, R. Kathryn ; Haller, Deborah L. ; Jacobs, Petra ; Gardin, John G. II ; Fischer, Daniel ; Rosen, Kristen D.
 Journal of Substance Abuse Treatment 2014;47(2):140-145. [doi: 10.1016/j.jsat.2014.03.004].
 
41. Clinically Relevant Characteristics Associated with Early Treatment Drug Use Versus Abstinence. doc type
  Cochran, Gerald ; Stitzer, Maxine L. ; Nunes, Edward V. ; Hu, Mei-Chen ; Campbell, Aimee N. C.
 Addiction Science & Clinical Practice 2014;9:6. [doi: 10.1186/1940-0640-9-6].
 
42. Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial. doc type
  Campbell, Aimee N. C. ; Nunes, Edward V. ; Matthews, Abigail G. ; Stitzer, Maxine L. ; Miele, Gloria M. ; Polsky, Daniel ; Turrigiano, Eva ; Walters, Scott ; McClure, Erin A. ; Kyle, Tiffany L. ; Wahle, Aimee ; VanVeldhuisen, Paul C. ; Goldman, Bruce ; Babcock, Dean ; Stabile, Patricia Q. ; Winhusen, Theresa M. ; Ghitza, Udi E.
 American Journal of Psychiatry 2014;171:683-690. [doi: 10.1176/appi.ajp.2014.13081055].
 
43. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
44. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
45. Concurrent Substance Abuse is Associated with Sexual Risk Behavior Among Adults Seeking Treatment for Prescription Opioid Dependence. doc type
  Meade, Christina S. ; Bevilacqua, Lisa A. ; Moore, Elizabeth D. ; Griffin, Margaret L. ; Gardin, John G. II ; Potter, Jennifer Sharpe ; Hatch-Maillette, Mary A. ; Weiss, Roger D.
 American Journal on Addictions 2014;23(1):27-33. [doi: 10.1111/j.1521-0391.2013.12057.x].
 
46. Effective Approaches to Addressing Patients with Substance Use Disorders in the Emergency Department: A Knowledge Exchange. [Blending Initiative Workshop] doc type doc type
  Ranney, Megan L. ; Saxon, Andrew J. ; Todd, Knox H. ; Babu, Kavita M. ; Boyer, Edward W. ; Ringwalt, Chris L. ; Neven, Darin E. ; Nelson, Lewis S. ; Graykoski, John J. ; D'Onofrio, Gail ; Zatzick, Douglas F. ; Cunningham, Rebecca M. ; Dunn, Christopher W. ; Bernstein, Edward ; Broderick, Kerryann B. ; Howard, Patricia K.
 Sponsored by the NIDA/SAMHSA Blending Initiative, American College of Emergency Physicians, and the Centers for Control and Prevention, Seattle, WA, October 13, 2013.
 
47. Early Treatment Drug Use: Drug Positive vs. Negative Patients. doc type
  Cochran, Gerald ; Stitzer, Maxine L. ; Nunes, Edward V. ; Hu, Mei-Chen ; Campbell, Aimee N. C.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
48. Opioid Withdrawal and Craving Trajectories Following Buprenorphine Taper: A Latent Class and Growth Mixture Model of Time-to-First Opioid Lapse. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Weiss, Roger D. ; Mulpur, Swetha ; Walker, N. Robrina ; Trivedi, Madhukar H.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
49. Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA's Clinical Trials Network (CTN). doc type
  Matthews, Abigail G. ; Hu, Lian ; Lu, Li ; VanVeldhuisen, Paul C. ; Tai, Betty ; Volkow, Nora D.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
50. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
51. 2013 Texas Addiction Research to Practice Conference. doc type doc type
  Stotts, Angela L. ; Walters, Scott ; Wakhlu, Sidarth
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 26, 2013.
 
52. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
53. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
54. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
55. Cross-System Response to the Opioid Epidemic. doc type
  Winstanley, Erin L. ; Walley, Alexander ; Brason, Fred Wells II ; Lancaster, Mike ; Davis, Corey ; Feinberg, Judith ; Roberts, Lisa ; Babcock, Dean ; Haag, Mary ; Krohn, Jo Anna
 Regional dissemination workshop sponsored by the CTN Ohio Valley Node, the Health Foundation of Greater Cincinnati, the Ohio Department of Health, and the Coalition for a Drug-Free Greater Cincinnati, November 12, 2012.
 
56. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
57. Substance Use, Treatment Admissions, and Recovery Trends in Diverse Washington State Tribal Communities. doc type
  Radin, Sandra M. ; Banta-Green, Caleb J. ; Thomas, Lisa Rey ; Kutz, Stephen H. ; Donovan, Dennis M.
 American Journal of Drug and Alcohol Abuse 2012;38(5):511-517. [doi: 10.3109/00952990.2012.694533].
 
58. American Indians with Substance Use Disorders: Treatment Needs and Comorbid Conditions. doc type
  Rieckmann, Traci R. ; McCarty, Dennis ; Kovas, Anne E. ; Spicer, Paul ; Bray, Joe ; Gilbert, Steve ; Mercer, Jacqueline
 American Journal of Drug and Alcohol Abuse 2012;38(5):498-504. [doi: 10.3109/00952990.2012.694530].
 
59. Characteristics of Northern Plains American Indians Seeking Substance Abuse Treatment in an Urban, Non-Tribal Clinic: A Descriptive Study. doc type
  Kropp, Frankie B. ; Somoza, Eugene C. ; Lilleskov, Maurine ; Moccasin, Mabel Granados-Bad ; Moore, Michelle ; Lewis, Daniel F. ; Boetel, Brenda ; Smith, Corey ; Winhusen, Theresa M.
 Community Mental Health Journal 2013;49:714-721. [doi: 10.1007/s10597-012-9537-7].
 
60. 2012 Texas Research to Practice Conference: Learn how Science is Impacting Addiction Treatment. doc type doc type doc type
  Trivedi, Madhukar H. ; Crowell, A. Rebecca ; Denton, Douglas ; Kosten, Thomas ; Potter, Jennifer Sharpe ; Hien, Denise A. ; Spence, Richard ; Levy, Michael S. ; Muir, Joan A.
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 30, 2012.
 
61. Buprenorphine Suite of Blending Products (Blending Team Product). doc type doc type
  Blending Team Members
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005-2012.
 
62. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
63. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
64. Waging the War Against the Devil in Scioto County: A Grassroots Response to Prescription Drug Abuse in a Rural Community. doc type
  Winstanley, Erin L. ; Gay, Joe R. ; Roberts, Lisa
 Presented at the Addiction Health Services Research (AHSR) conference, Fairfax, VA, October 3-5, 2011.
 
65. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial. doc type
  Back, Sudie E. ; Payne, Rebecca ; Wahlquist, Amy Herrin ; Carter, Rickey E. ; Stroud, Zachary ; Haynes, Louise F. ; Hillhouse, Maureen P. ; Brady, Kathleen T. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):313-323. [doi: 10.3109/00952990.2011.596982].
 
66. Assessing Drug Use during Follow-Up: Direct Comparison of Candidate Outcome Definitions in Pooled Analyses of Addiction Treatment Studies. doc type
  Korte, Jeffrey E. ; Magruder, Kathryn M. ; Chiuzan, Codruta C. ; Logan, Sarah L. ; Killeen, Therese ; Bandyopadhyay, Dipankar ; Brady, Kathleen T.
 American Journal of Drug and Alcohol Abuse 2011;37(5):358-366. [doi: 10.3109/00952990.2011.602997].
 
67. A Multi-Level Analysis of Counselor Attitudes Toward the Use of Buprenorphine in Substance Abuse Treatment. doc type
  Rieckmann, Traci R. ; Kovas, Anne E. ; McFarland, Bentson H. ; Abraham, Amanda J.
 Journal of Substance Abuse Treatment 2011;41(4):374-385. [doi: 10.1016/j.jsat.2011.05.005].
 
68. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
69. What the National Institute on Drug Abuse's Clinical Trials Network Can Do For You? Major Findings from Medication Trials and Implications for Community-Based Settings. doc type
  Weiss, Roger D.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
70. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
71. Alterations in Brain Structure and Functional Connectivity in Prescription Opioid-Dependent Patients. doc type
  Upadhyay, Jaymin ; Maleki, Nasim ; Potter, Jennifer Sharpe ; Elman, Igor ; Rudrauf, David ; Knudsen, Jaime ; Wallin, Diane ; Pendse, Gautam ; McDonald, Leah ; Griffin, Margaret L. ; Anderson, Julie ; Nutile, Lauren ; Renshaw, Perry ; Weiss, Roger D. ; Becerra, Lino ; Borsook, David
 Brain 2010;133(7):2098-2114. [doi: 10.1093/brain/awq138].
 
72. Buprenorphine Treatment of Prescription Opiate Addiction. doc type
  McCarthy, John
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
73. Young Opioid Abusers Benefit from Extended Buprenorphine-Naloxone Treatment. doc type
  Whitten, Lori
 NIDA Notes 2010;23(1):8-9.
 
74. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
75. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
76. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
77. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
78. Predictors of Buprenorphine-Naloxone Dosing in a 12-Week Treatment Trial for Opioid-Dependent Youth: Secondary Analyses from a NIDA Clinical Trials Network Study. doc type
  Chakrabarti, Amit ; Woody, George E. ; Griffin, Margaret L. ; Subramaniam, Geetha A. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2010;107(2-3):253-256. [doi: 10.1016/j.drugalcdep.2009.10.014].
 
79. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
80. Clinical Characteristics of Treatment-Seeking Prescription Opioid vs. Heroin-Using Adolescents with Opioid Use Disorder. doc type
  Subramaniam, Geetha A. ; Stitzer, Maxine L.
 Drug and Alcohol Dependence 2009;101(1-2):13-19. [doi: 10.1016/j.drugalcdep.2008.10.015].
 

New Search